Solid Biosciences Inc. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
Solid Biosciences Inc. (SLDB) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of -$1.44 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-06
- Solid Biosciences Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was -$969.00K, a 149.19% decline year-over-year.
- Solid Biosciences Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was -$473.00K.
- Solid Biosciences Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was $152.00K, a 90.64% decline year-over-year.
- Solid Biosciences Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was $2.20M, a 33.42% decline year-over-year.
- Solid Biosciences Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was $4.05M, a 15.02% decline from fiscal 2024.
- Solid Biosciences Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was $4.77M.
- Solid Biosciences Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was -$6.97M, a 219.46% decline from fiscal 2022.
- Solid Biosciences Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was $5.83M.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$969.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.44M 10-Q · filed 2026-08-06 | -$1.29M derived: sum of 3 quarters · filed 2026-08-06 | $913.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$473.00K 10-Q · filed 2026-05-12 | -$321.00K derived: sum of 2 quarters · filed 2026-05-12 | $1.88M derived: sum of 3 quarters · filed 2026-05-12 | $3.85M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $152.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $2.35M derived: sum of 2 quarters · filed 2026-03-19 | $4.33M derived: sum of 3 quarters · filed 2026-08-06 | $4.05M 10-K · filed 2026-03-19 | ||||
| 2025-09-30 | $2.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $4.17M derived: sum of 2 quarters · filed 2026-08-06 | $3.90M 10-Q · filed 2025-11-03 | $5.52M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $1.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.70M 10-Q · filed 2026-08-06 | $3.32M derived: sum of 3 quarters · filed 2026-08-06 | $6.63M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$275.00K 10-Q · filed 2026-05-12 | $1.35M derived: sum of 2 quarters · filed 2026-05-12 | $4.66M derived: sum of 3 quarters · filed 2026-05-12 | $4.28M derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | $1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $4.93M derived: sum of 2 quarters · filed 2026-03-19 | $4.55M derived: sum of 3 quarters · filed 2026-03-19 | $4.77M 10-K · filed 2026-03-19 | ||||
| 2024-09-30 | $3.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $2.93M derived: sum of 2 quarters · filed 2025-11-03 | $3.14M 10-Q · filed 2025-11-03 | $1.50M derived: sum of 4 quarters · filed 2025-11-03 | ||||
| 2024-06-30 | -$380.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$167.00K 10-Q · filed 2025-08-12 | -$1.81M derived: sum of 3 quarters · filed 2025-08-12 | -$906.00K derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | $213.00K 10-Q · filed 2025-05-15 | -$260.00K 10-Q · filed 2024-05-15 | -$1.43M derived: sum of 2 quarters · filed 2025-05-15 | -$526.00K derived: sum of 3 quarters · filed 2025-05-15 | -$1.84M derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | -$1.65M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$739.00K derived: sum of 2 quarters · filed 2025-03-06 | -$2.06M derived: sum of 3 quarters · filed 2025-03-06 | -$6.97M 10-K · filed 2025-03-06 | -$9.01M 10-K · filed 2024-03-13 | |||
| 2023-09-30 | $906.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$411.00K derived: sum of 2 quarters · filed 2024-11-06 | -$5.32M 10-Q · filed 2024-11-06 | -$6.89M 10-Q · filed 2023-11-08 | -$2.75M derived: sum of 4 quarters · filed 2024-11-06 | |||
| 2023-06-30 | -$1.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$6.23M 10-Q · filed 2024-08-13 | -$7.32M 10-Q · filed 2023-08-14 | -$3.66M derived: sum of 3 quarters · filed 2024-08-13 | -$8.63M derived: sum of 4 quarters · filed 2024-08-13 | |||
| 2023-03-31 | -$4.91M 10-Q · filed 2024-05-15 | -$2.34M derived: sum of 2 quarters · filed 2024-05-15 | -$7.31M derived: sum of 3 quarters · filed 2024-05-15 | $1.37M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $2.57M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | -$2.40M derived: sum of 2 quarters · filed 2024-03-13 | $6.28M derived: sum of 3 quarters · filed 2024-03-13 | $5.83M 10-K · filed 2024-03-13 | ||||
| 2022-09-30 | -$4.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $3.71M derived: sum of 2 quarters · filed 2023-11-08 | $3.26M 10-Q · filed 2023-11-08 | $5.84M derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2022-06-30 | $8.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $8.23M 10-Q · filed 2023-08-14 | $10.80M derived: sum of 3 quarters · filed 2024-03-13 | $10.50M derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2022-03-31 | -$445.00K 10-Q · filed 2023-05-11 | $2.13M derived: sum of 2 quarters · filed 2024-03-13 | $1.83M derived: sum of 3 quarters · filed 2024-03-13 | $1.22M derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2021-12-31 | $2.58M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $2.27M derived: sum of 2 quarters · filed 2024-03-13 | $1.66M derived: sum of 3 quarters · filed 2024-03-13 | -$2.25M 10-K · filed 2024-03-13 | ||||
| 2021-09-30 | -$302.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$915.00K derived: sum of 2 quarters · filed 2022-11-10 | -$4.83M 10-Q · filed 2022-11-10 | -$3.94M derived: sum of 4 quarters · filed 2023-03-23 | ||||
| 2021-06-30 | -$613.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$4.53M 10-Q · filed 2022-08-11 | -$3.64M derived: sum of 3 quarters · filed 2023-03-23 | -$3.87M derived: sum of 4 quarters · filed 2023-03-23 | ||||
| 2021-03-31 | -$3.92M 10-Q · filed 2022-04-27 | -$3.03M derived: sum of 2 quarters · filed 2023-03-23 | -$3.25M derived: sum of 3 quarters · filed 2023-03-23 | -$3.90M derived: sum of 4 quarters · filed 2023-03-23 | ||||
| 2020-12-31 | $887.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $661.00K derived: sum of 2 quarters · filed 2023-03-23 | $18.00K derived: sum of 3 quarters · filed 2023-03-23 | -$1.16M 10-K · filed 2023-03-23 | ||||
| 2020-09-30 | -$226.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$869.00K derived: sum of 2 quarters · filed 2021-11-03 | -$2.04M 10-Q · filed 2021-11-03 | -$4.97M derived: sum of 4 quarters · filed 2022-03-14 | ||||
| 2020-06-30 | -$643.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$1.82M 10-Q · filed 2021-08-16 | -$4.74M derived: sum of 3 quarters · filed 2022-03-14 | $359.00K derived: sum of 4 quarters · filed 2022-03-14 | ||||
| 2020-03-31 | -$1.18M 10-Q · filed 2021-05-14 | -$4.10M derived: sum of 2 quarters · filed 2022-03-14 | $1.00M derived: sum of 3 quarters · filed 2022-03-14 | -$433.00K derived: sum of 4 quarters · filed 2022-03-14 | ||||
| 2019-12-31 | -$2.92M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $2.18M derived: sum of 2 quarters · filed 2022-03-14 | $742.00K derived: sum of 3 quarters · filed 2022-03-14 | -$510.00K 10-K · filed 2022-03-14 | ||||
| 2019-09-30 | $5.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $3.67M derived: sum of 2 quarters · filed 2020-11-05 | $2.41M 10-Q · filed 2020-11-05 | $5.11M derived: sum of 4 quarters · filed 2021-03-15 | ||||
| 2019-06-30 | -$1.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$2.69M 10-Q · filed 2020-08-06 | $11.00K derived: sum of 3 quarters · filed 2021-03-15 | $1.00M derived: sum of 4 quarters · filed 2021-03-15 | ||||
| 2019-03-31 | -$1.25M 10-Q · filed 2020-05-07 | $1.45M derived: sum of 2 quarters · filed 2021-03-15 | $2.44M derived: sum of 3 quarters · filed 2021-03-15 | $2.98M derived: sum of 4 quarters · filed 2021-03-15 | ||||
| 2018-12-31 | $2.70M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $3.69M derived: sum of 2 quarters · filed 2021-03-15 | $4.23M derived: sum of 3 quarters · filed 2021-03-15 | $2.88M 10-K · filed 2021-03-15 | ||||
| 2018-09-30 | $990.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $1.54M derived: sum of 2 quarters · filed 2019-11-12 | $185.00K 10-Q · filed 2019-11-12 | $1.18M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2018-06-30 | $546.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$805.00K 10-Q · filed 2019-08-14 | $186.00K derived: sum of 3 quarters · filed 2020-03-12 | $164.00K derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2018-03-31 | -$1.35M 10-Q · filed 2019-05-13 | -$360.00K derived: sum of 2 quarters · filed 2020-03-12 | -$382.00K derived: sum of 3 quarters · filed 2020-03-12 | $1.41M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2017-12-31 | $991.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $969.00K derived: sum of 2 quarters · filed 2020-03-12 | $2.76M derived: sum of 3 quarters · filed 2020-03-12 | $2.04M 10-K · filed 2020-03-12 | ||||
| 2017-09-30 | -$22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $1.77M derived: sum of 2 quarters · filed 2018-11-13 | $1.04M 10-Q · filed 2018-11-13 | |||||
| 2017-06-30 | $1.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $1.07M 10-Q · filed 2018-08-10 | ||||||
| 2017-03-31 | -$725.00K 10-Q · filed 2018-05-10 | |||||||
| 2016-12-31 | $2.58M 10-K · filed 2019-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |